一份静脉输液知情同意书

2018-02-07 Gcplive 药评中心

您好!根据您的病情,我门诊需要为您进行静脉输液治疗。现将有关事项向您说明如下,请您在接受治疗前务必仔细阅读。如您有任何不明之处,敬请及时提出,您将会得到医护人员相应的解答。


尊敬的患者:

您好!根据您的病情,我门诊需要为您进行静脉输液治疗。现将有关事项向您说明如下,请您在接受治疗前务必仔细阅读。如您有任何不明之处,敬请及时提出,您将会得到医护人员相应的解答。

一、静脉输液有较大的风险性,常见不良反应包括:

1、过敏反应。轻则表现为皮疹、哮喘、发热;重则发生休克,甚至危及生命。某些药品即使皮试阴性,仍可能出现过敏反应;某些药品不要求过敏试验,但也可能出现过敏反应。

2、输液反应。主要表现为发冷、寒战、面部和四肢发绀,继而发热,体温可达41~42℃。绝大多数输液反应经对症处理可以短期内治愈,少数输液反应可导致死亡。

3、局部刺激、渗液、出血或感染。常见但不严重,经对症处理可以短期内消失,个别出现静脉炎,与个人体质有关。

4、药物副作用。药品说明书已经指出药品本身的副作用等,与静脉输液本身无关,请您详细阅读药品说明书。

5、其他不可预知的不良反应。

医护人员将严格遵守操作规程,将上述风险降至最低程度,但当前医疗水平对上述风险不能预测和完全避免,我门诊无法承诺避免,出现上述反应时,抢救费、治疗费用等需要您自己承担。

二、输液过程中,请您务必牢记以下二点:

1、如果出现皮疹、呕吐、心慌、憋气、寒战、局部皮下血肿或组织水肿等情况,请您立即与医护人员联系,同时停止输液。

2、不要自行调整输液速度(滴数),以防止因输液速度过快而出现急性心力衰竭,或药物中毒等。

三、输液后的注意事项

1、拔针后注意按压,按压时切记不要揉按,以防造成血管穿刺点的隐性出血,导致局部皮肤青紫,严重的将形成血肿。

2、在输液完成后,请您不要突然起身或变化体位,以防意外发生。

四、当发生输液问题纠纷时,若对用药或输液质量产生怀疑,请告知护理人员,由双方封存;您和家人不要抢夺,否则,依法由您承担一切后果。

医生/护士签名:_________

知情同意:我已仔细阅读(或由家属/护士向我宣读)上文并理解其含义,了解了可能发生的各种风险。对于我提出的问题,医护人员已经进行了详细的解答。我申请并同意医院为我进行静脉输液治疗。

患者或代理人签字:_________与患者的关系:_________

年    月    日

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1697637, encodeId=693f169e63720, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Sep 26 18:02:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436950, encodeId=a5291436950fc, content=<a href='/topic/show?id=43ad9919867' target=_blank style='color:#2F92EE;'>#静脉输液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99198, encryptionId=43ad9919867, topicName=静脉输液)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 09 12:02:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512389, encodeId=ec86151238948, content=<a href='/topic/show?id=6863e314797' target=_blank style='color:#2F92EE;'>#知情同意#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73147, encryptionId=6863e314797, topicName=知情同意)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a410466491, createdName=1249862am75(暂无昵称), createdTime=Fri Feb 09 12:02:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584248, encodeId=52f31584248e3, content=<a href='/topic/show?id=cc4ae3148c4' target=_blank style='color:#2F92EE;'>#知情同意书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73148, encryptionId=cc4ae3148c4, topicName=知情同意书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40e17038630, createdName=12498f1em13(暂无昵称), createdTime=Fri Feb 09 12:02:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286042, encodeId=e2da2860424b, content=本无奈.而为之., beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Feb 07 22:23:01 CST 2018, time=2018-02-07, status=1, ipAttribution=)]
    2018-09-26 fusion
  2. [GetPortalCommentsPageByObjectIdResponse(id=1697637, encodeId=693f169e63720, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Sep 26 18:02:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436950, encodeId=a5291436950fc, content=<a href='/topic/show?id=43ad9919867' target=_blank style='color:#2F92EE;'>#静脉输液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99198, encryptionId=43ad9919867, topicName=静脉输液)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 09 12:02:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512389, encodeId=ec86151238948, content=<a href='/topic/show?id=6863e314797' target=_blank style='color:#2F92EE;'>#知情同意#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73147, encryptionId=6863e314797, topicName=知情同意)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a410466491, createdName=1249862am75(暂无昵称), createdTime=Fri Feb 09 12:02:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584248, encodeId=52f31584248e3, content=<a href='/topic/show?id=cc4ae3148c4' target=_blank style='color:#2F92EE;'>#知情同意书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73148, encryptionId=cc4ae3148c4, topicName=知情同意书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40e17038630, createdName=12498f1em13(暂无昵称), createdTime=Fri Feb 09 12:02:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286042, encodeId=e2da2860424b, content=本无奈.而为之., beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Feb 07 22:23:01 CST 2018, time=2018-02-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1697637, encodeId=693f169e63720, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Sep 26 18:02:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436950, encodeId=a5291436950fc, content=<a href='/topic/show?id=43ad9919867' target=_blank style='color:#2F92EE;'>#静脉输液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99198, encryptionId=43ad9919867, topicName=静脉输液)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 09 12:02:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512389, encodeId=ec86151238948, content=<a href='/topic/show?id=6863e314797' target=_blank style='color:#2F92EE;'>#知情同意#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73147, encryptionId=6863e314797, topicName=知情同意)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a410466491, createdName=1249862am75(暂无昵称), createdTime=Fri Feb 09 12:02:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584248, encodeId=52f31584248e3, content=<a href='/topic/show?id=cc4ae3148c4' target=_blank style='color:#2F92EE;'>#知情同意书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73148, encryptionId=cc4ae3148c4, topicName=知情同意书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40e17038630, createdName=12498f1em13(暂无昵称), createdTime=Fri Feb 09 12:02:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286042, encodeId=e2da2860424b, content=本无奈.而为之., beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Feb 07 22:23:01 CST 2018, time=2018-02-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1697637, encodeId=693f169e63720, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Sep 26 18:02:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436950, encodeId=a5291436950fc, content=<a href='/topic/show?id=43ad9919867' target=_blank style='color:#2F92EE;'>#静脉输液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99198, encryptionId=43ad9919867, topicName=静脉输液)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 09 12:02:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512389, encodeId=ec86151238948, content=<a href='/topic/show?id=6863e314797' target=_blank style='color:#2F92EE;'>#知情同意#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73147, encryptionId=6863e314797, topicName=知情同意)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a410466491, createdName=1249862am75(暂无昵称), createdTime=Fri Feb 09 12:02:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584248, encodeId=52f31584248e3, content=<a href='/topic/show?id=cc4ae3148c4' target=_blank style='color:#2F92EE;'>#知情同意书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73148, encryptionId=cc4ae3148c4, topicName=知情同意书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40e17038630, createdName=12498f1em13(暂无昵称), createdTime=Fri Feb 09 12:02:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286042, encodeId=e2da2860424b, content=本无奈.而为之., beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Feb 07 22:23:01 CST 2018, time=2018-02-07, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1697637, encodeId=693f169e63720, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Sep 26 18:02:00 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436950, encodeId=a5291436950fc, content=<a href='/topic/show?id=43ad9919867' target=_blank style='color:#2F92EE;'>#静脉输液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99198, encryptionId=43ad9919867, topicName=静脉输液)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 09 12:02:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512389, encodeId=ec86151238948, content=<a href='/topic/show?id=6863e314797' target=_blank style='color:#2F92EE;'>#知情同意#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73147, encryptionId=6863e314797, topicName=知情同意)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a410466491, createdName=1249862am75(暂无昵称), createdTime=Fri Feb 09 12:02:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584248, encodeId=52f31584248e3, content=<a href='/topic/show?id=cc4ae3148c4' target=_blank style='color:#2F92EE;'>#知情同意书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73148, encryptionId=cc4ae3148c4, topicName=知情同意书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40e17038630, createdName=12498f1em13(暂无昵称), createdTime=Fri Feb 09 12:02:00 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286042, encodeId=e2da2860424b, content=本无奈.而为之., beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Feb 07 22:23:01 CST 2018, time=2018-02-07, status=1, ipAttribution=)]
    2018-02-07 1e0f8808m18(暂无匿称)

    本无奈.而为之.

    0

相关资讯

静脉输液不慎发生空气栓塞,怎么办?

空气栓塞是威胁生命的并发症,治疗难、预后差,所以预防工作非常重要。空气进入血管,确实能引起气体栓塞,但要视进入气体量的多少而定。如空气量小,可分散到肺泡毛细血管,与血红蛋白结合。或弥散至肺泡,随呼吸排出体外,因而不造成损害。但进入空气量大且比较迅速,则由于心脏的搏动,将空气和心腔内的血液搅拌形成大量泡沫,当心收缩时不被排出或阻塞肺动脉可导致猝死。一般迅速进入血循环的空气在100毫升左右时,即可导致

Blood:细胞外液张力对镰状红细胞的可塑性和黏附性的影响。

异常镰状红细胞(sRBC)的生物力学,包括病理形变和粘连,与镰状细胞病(SCD)的临床严重程度相关。各种张力的临床静脉输液(IVFs)常用于治疗血管闭塞性疼痛(VOE),这是SCD发病的主要原因。然而,缺乏基于证据的指南,且在VOE中应该使用哪一种张力的IVFs尚未达成共识。而且,在微循环中,用IVFs改变胞外流体的张力是如何影响sRBC的生物力学也不清楚。

对于输液港,你知道多少?

输液港的注射座和静脉外的导管部分均埋藏于皮下组织,是一种植入式、可长期留置的中心静脉输液装置。需要行小手术置入。

触目惊心!一例静滴药物外渗造成的严重并发症

也许你有点不敢相信自己的眼睛,图片中,患者这只输液的手上出现的骨筋膜室综合症和张力性大疱,如此后果严重、令人触目惊心的并发症竟然是由于静脉输液药物外渗引起的!

广西桂林二级及以上医疗机构将全面停止门诊静脉输液

广西桂林市卫生和计划生育委员会近日下发《关于加强医疗机构静脉输液管理的通知》,规定二级及以上医疗机构于2018年1月1日起,除儿科门诊和急诊科外,全面停止门诊静脉输液服务。

临床实践:穿刺你应该知道的事

静脉输液是临床治疗、抢救用药最常用的基础护理操作技术之一,穿刺的成功与否、有无疼痛是患者和护士共同关注的焦点。在临床实践中,我们改进了传统的静脉输液操作方法,减轻了患者的疼痛,提高了穿刺成功率。